Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial. - PRESTO

Description:

The goal of this study was to assess the safety and efficacy of the oral agent tranilast in decreasing the frequency of angiographic restenosis among patients receiving percutaneous coronary intervention (PCI).